MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-14-2026
Precipio Cash Conversion Cycle 2011-2026 | PRPO
Annual Cash Conversion Cycle Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.9 | 18.5 | -3.19 | -36 | -42.3 | -46.8 | -153 | -600 | -1.11 K | -1.3 K | -644 | 63.6 | - | - | - | 35.2 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 63.6 | -1.3 K | -292 |
Quarterly Cash Conversion Cycle Precipio
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 17.7 | 17.2 | 16.8 | - | 13.8 | 11.1 | 18.2 | - | -40.9 | -51.6 | -35 | - | -43.8 | -62.6 | -46.5 | - | -36.7 | -58.3 | -58 | - | -49 | -46.8 | -75.1 | - | -145 | -152 | -374 | - | -590 | -630 | -566 | - | -1.05 K | -1.33 K | -1.41 K | - | -311 | -1.36 K | -831 | - | -692 | -678 | -704 | 34.7 | 104 | 63.9 | 85.1 | 78 | 96.8 | 89.5 | 129 | 101 | 161 | 142 | 147 | 80.6 | 114 | 127 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 161 | -1.41 K | -204 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-2.46 K | $ 4.5 | -10.89 % | $ 5.99 M | USA |
 |
Fulgent Genetics
FLGT
|
51.8 | $ 18.5 | 1.04 % | $ 569 M | USA |
 |
Castle Biosciences
CSTL
|
31.6 | $ 21.08 | 4.77 % | $ 611 M | USA |
 |
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
2.11 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
52.5 | $ 151.82 | -0.28 % | $ 11.9 B |  Irlanda |
 |
Illumina
ILMN
|
147 | $ 160.03 | 1.26 % | $ 24.8 B | USA |
 |
Guardant Health
GH
|
79.6 | $ 130.12 | 4.19 % | $ 16.3 B | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 22.75 | 3.64 % | $ 1.21 B | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
Interpace Biosciences
IDXG
|
62.9 | $ 1.74 | 3.57 % | $ 7.7 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
NeoGenomics
NEO
|
82.4 | $ 11.44 | 4.47 % | $ 1.47 B | USA |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
29.4 | $ 19.75 | 2.17 % | $ 442 M | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 99.98 | -0.03 % | $ 6.75 B | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 189.85 | 1.83 % | $ 9.41 B | USA |
 |
Pacific Biosciences of California
PACB
|
185 | $ 1.37 | -0.72 % | $ 411 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 466.79 | 1.94 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 162.79 | 2.1 % | $ 24 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
49.3 | $ 4.54 | 3.42 % | $ 420 M | USA |
 |
Natera
NTRA
|
48.3 | $ 222.82 | 4.38 % | $ 30.5 B | USA |
 |
Personalis
PSNL
|
-1.89 | $ 9.75 | -2.89 % | $ 870 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 26.5 | 2.63 % | $ 25.1 B |  Niderland |
 |
Senseonics Holdings
SENS
|
36.1 | $ 7.43 | 4.21 % | $ 310 M | USA |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
-398 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
172 | $ 2.05 | -0.92 % | $ 4.71 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 271.24 | 3.52 % | $ 22.6 B | USA |
 |
Twist Bioscience Corporation
TWST
|
83.6 | $ 70.06 | 0.03 % | $ 4.19 B | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 494.07 | 5.23 % | $ 186 B | USA |
 |
Trinity Biotech plc
TRIB
|
136 | $ 0.66 | -2.32 % | $ 237 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
150 | $ 9.29 | 2.43 % | $ 2.01 B | USA |
 |
Waters Corporation
WAT
|
731 | $ 371.15 | 2.15 % | $ 22.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 204.53 | 3.71 % | $ 22.7 B | USA |